Loading...

China Oncology

30 July 2022, Volume 32 Issue 7
Cover and contents

2022 Issue 7 Cover

Abstract ( 143) PDF (3148KB) ( 274 )

Contents of Issue 7, 2022

2022, 32 (7): 2-2.

Abstract ( 83) PDF (10607KB) ( 229 )

Specialists' Commentary

The current data and challenge of radiotherapy in the case management of gastric cancer

CAI Gang, WANG Shubei, CHEN Jiayi

2022, 32 (7): 581-587. doi: 10.19401/j.cnki.1007-3639.2022.07.001

Abstract ( 527) PDF (1597KB) ( 851 ) HTML ( 738 )

Specialists' Article

Analysis of risk factors of early recurrence and metastasis after radical resection of gastric cancer

CAO Mengxuan, HU Can, ZHANG Yanqiang, HUANG Ling, DU Yian, YU Pengcheng, ZHANG Ruolan, XU Zhiyuan, CHENG Xiangdong

2022, 32 (7): 588-595. doi: 10.19401/j.cnki.1007-3639.2022.07.002

Abstract ( 475) PDF (1599KB) ( 746 ) HTML ( 45 )

Article

Optimization of 5-FU metronomic chemotherapy strategy and regulation of the immune microenvironment in gastric cancer: an in vivo study

JIANG Jinling, ZHOU Chenfei, XI Wenqi, SHI Min, GEN Mei, ZHAO Liqin, CAI Qu, JIANG Jinsong, ZHANG Jun

2022, 32 (7): 596-605. doi: 10.19401/j.cnki.1007-3639.2022.07.003

Abstract ( 450) PDF (2407KB) ( 563 ) HTML ( 75 )

Establishment of a mouse myocarditis model induced by programmed death-1 inhibitor

CHEN Yifan, CHENG Leilei, SHEN Yihui, ZHANG Hui, WANG Xuejun, XU Yuchen, GE Junbo

2022, 32 (7): 606-613. doi: 10.19401/j.cnki.1007-3639.2022.07.004

Abstract ( 275) PDF (3887KB) ( 476 ) HTML ( 8 )

NLK inhibits the transformation from prostatitis to prostate cancer through maintaining NF-κB/P53 functional balance

WANG Jian, DING Congcong, LU Yan, LI Tong

2022, 32 (7): 614-623. doi: 10.19401/j.cnki.1007-3639.2022.07.005

Abstract ( 244) PDF (1678KB) ( 525 ) HTML ( 9 )

Efficacy and prognostic predictors of first-generation EGFR TKI-targeted therapy in patients with EGFR-mutated advanced non-small cell lung cancer

HONG Yaping, HUANG Yunjian, HUANG Zhangzhou, CHEN Shengjia, ZHONG Qiaofeng, ZENG Hongfu, ZHUANG Wu

2022, 32 (7): 624-634. doi: 10.19401/j.cnki.1007-3639.2022.07.006

Abstract ( 485) PDF (1524KB) ( 582 ) HTML ( 60 )

Review

Application progress of single-cell sequencing technology in breast cancer research

LIU Qiang, FANG Yi, WANG Jing

2022, 32 (7): 635-642. doi: 10.19401/j.cnki.1007-3639.2022.07.007

Abstract ( 364) PDF (1416KB) ( 781 ) HTML ( 50 )

Research progress and prospects of neoadjuvant endocrine therapy for breast cancer

QIAN Yao, LIU Feng

2022, 32 (7): 643-649. doi: 10.19401/j.cnki.1007-3639.2022.07.008

Abstract ( 386) PDF (1556KB) ( 881 ) HTML ( 516 )

Case Report

A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder

LIU Yanquan, HU Xiaomei, YIN Yue, LIN Lin, SHEN Jianzhen, CHEN Yuting, TANG Huanwen

2022, 32 (7): 650-656. doi: 10.19401/j.cnki.1007-3639.2022.07.009

Abstract ( 400) PDF (1717KB) ( 622 ) HTML ( 520 )

Guideline and Consensus

Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version)

The Society of Cancer Multidisciplinary Diagnosis and Treatment, China Anti-Cancer Association, The Society of Cancer Endocrinology, China Anti-Cancer Association

2022, 32 (7): 657-668. doi: 10.19401/j.cnki.1007-3639.2022.07.010

Abstract ( 853) PDF (1556KB) ( 1042 ) HTML ( 677 )

中国癌症杂志
    Database Indexing
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • Outsanding S&T Journals of China (2020) (F5000)
  • World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
  • SCOPUS
  • EMBASE
  • DOAJ
  • Chemical Abstracts (CA)
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)
  • EBSCO
  • Index of Copernicus International (ICI)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHAO Zhimin

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat